NCT06687369 2026-03-11A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)mAbxience Research S.L.Phase 3 Recruiting726 enrolled